Upendra Kaul on Muck Rack

Upendra Kaul

As seen in: Hindustan Times, The Indian Express, Rediff.com, The Hindu, JAMA Cardiology, Business Standard, The Wire (India), MENAFN, Greater Kashmir, Rising Kashmir and
Upendra Kaul is a Cardiologist and Researcher. He has been awarded the Dr. B. C. Roy Award and Padma Shri.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Upendra

Contact Upendra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Evolutionary Baseline: From Primates to the Current Humans

|
By Upendra Kaul
| Greater Kashmir
Listen to this article To understand the modern crisis of “bad cholesterol”—specifically Low-Density Lipoprotein Cholesterol (LDL-C)—we must look at our evolutionary design. Biologically, humans are “the fat primate.” While our closest living relatives, like chimpanzees and rhesus monkeys, maintain a total body fat percentage of less than 9%, a healthy human range spans from 14% to 31%.
Open in Who Shared Issue with article?

Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention : A Systematic Review and Meta-Analysis

|
By M. Maqsood, Frederick Feit, Upendra Kaul, Sunil V. Rao, Daniele Giacoppo, Adnan Kastrati, Sripal Bangalore
| JAMA Cardiology
Key Points Question Which of the oral P2Y purinergic receptor 12 (P2Y12) inhibitors provides the optimal efficacy and safety in patients after percutaneous coronary intervention (PCI)? Findings In this systematic review and meta-analysis, there was a lower risk of major adverse cardiovascular events (MACE) with prasugrel compared to clopidogrel and compared to ticagrelor driven by lower myocardial infarction and lower stent thrombosis.
Open in Who Shared Issue with article?

Key Takeaways from Euro PCR 2026

|
By Upendra Kaul
| Greater Kashmir
Listen to this article Every spring, Paris shifts from being merely the global capital of culture and history to the vibrant epicentre of interventional cardiovascular medicine. As thousands of clinicians, researchers, and allied health professionals converge upon the Palais des Congrès for Euro-PCR, the city provides far more than a scenic backdrop; it embodies the very spirit of the course itself.
Open in Who Shared Issue with article?
See all 429 licensed articles (433 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Upendra

Contact Upendra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified